Lynn Kirkpatrick insider trades: Ensysce Biosciences (ENSC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lynn reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 26, 2022 | ENSC | ↑ Buy | 97,000 | $0.50 | $48K | Direct | May 27, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ENSC insiders
Open-market trades in the last 12 months
About Lynn Kirkpatrick's insider trades
Lynn Kirkpatrick is Chief Executive Officer at Ensysce Biosciences (ENSC). Since May 26, 2022, Lynn has reported 1 open-market purchase worth $48K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENSC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.